Initially described in 1986, XP11 tRCC is defined by the fusion between the TFE3 transcription factor gene (locus Xp11.2) and different partner genes. This evidence concerns the gene TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.